Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/19/12 → 10/18/16 |
Funding
- Bayer Healthcare Pharmaceuticals Incorporated: $56,213.75
Phase II/III Partial randomized open lable trial comparing prophylactic treatment with BAY 94-9027 (at once and twice a week dosing) to on demand infusion
- Gilligan, Diana (PI)
- Coyle, Thomas (PI)
Project: Research